ControversiesChallengesConsensus
}

CX 2020 LIVE: Deep venous session to examine stent durability and design

2020-06-11T13:20:21+01:00

Armando Mansilha (Porto, Portugal), who is also a member of the CX Venous Executive Board, welcomes you to the Deep Venous Disease Consensus session at CX 2020 LIVE. Deep venous disease is a “significant medical problem for patients” and also a “substantial burden for our healthcare systems”, notes Mansilha.

In […]

CX 2020 LIVE: Deep venous session to examine stent durability and design2020-06-11T13:20:21+01:00

CX 2020 LIVE aortic arch discussion highlights importance of underlying pathology and benefit of multidisciplinary team

2020-06-05T17:33:02+01:00

Roger Greenhalgh (top left), Stéphan Haulon (top right), Ludovic Canaud (bottom left), and Gustavo Oderich (bottom right)

This week, the CX 2020 LIVE agenda turned to the technically challenging topic of aortic arch interventions. Through presentations, discussion, and polling, the session—chaired by Roger Greenhalgh (London, UK) and […]

CX 2020 LIVE aortic arch discussion highlights importance of underlying pathology and benefit of multidisciplinary team2020-06-05T17:33:02+01:00

CX 2020 LIVE panel considers advances in thoracic care with new developments in TEVAR

2020-06-05T15:07:47+01:00

Ali Azizzadeh (top) chaired the CX 2020 LIVE Industry Symposium, which featured contributions from Hence Verghagen (bottom row left), Richard Gibbs (bottom row left), and Santi Trimarchi (bottom row right)

Benefits of using angulation control in thoracic endovascular aortic repair (TEVAR), an update […]

CX 2020 LIVE panel considers advances in thoracic care with new developments in TEVAR2020-06-05T15:07:47+01:00

Nearly 70% of CX 2020 LIVE global aortic audience finds type II endoleak without sac expansion harmless

2020-06-02T09:04:25+01:00

Roger Greenhalgh (top left), Ian Loftus (top right), Lindsay Machan (bottom left), and Gustavo Oderich (bottom right)

A global audience tuned into the second session and inaugural aortic offering of CX 2020 LIVE. […]

Nearly 70% of CX 2020 LIVE global aortic audience finds type II endoleak without sac expansion harmless2020-06-02T09:04:25+01:00

CX 2020 LIVE pioneers virtual vascular conference format in COVID-19 era

2020-06-02T09:11:44+01:00

Chair Roger Greenhalgh (top left), moderator Andrew Holden (top right), Sapan Desai (bottom left), Sabine Steiner (bottom middle), and Misti Malone (bottom right)

CX 2020 LIVE came to life online—despite COVID-19—using state-of-the art broadcast technology to bring together more than 1,000 vascular specialists, […]

CX 2020 LIVE pioneers virtual vascular conference format in COVID-19 era2020-06-02T09:11:44+01:00

Covered endoprostheses gain key role in management of aortoiliac occlusive disease

2020-06-02T08:57:44+01:00

Michele Antonello (top) chairs the discussion, following the Industry Symposium, with Amer Zanabili and Bella Huasen.

The first session of CX 2020 LIVE also featured an Industry Symposium titled “Endovascular treatment of complex aortoiliac occlusive disease” (sponsored by Gore). Chaired by Michele Antonello […]

Covered endoprostheses gain key role in management of aortoiliac occlusive disease2020-06-02T08:57:44+01:00

CX 2020 LIVE: Vascular Access education and innovation “imperative” during COVID-19 crisis

2020-05-22T16:58:23+01:00


CX 2020 LIVE will consist of 10 live sessions, which will feature audience participation, and run from 16:00 BST/11:00 EDT/17:00 CEST every Tuesday and Thursday, from 26 May until 25 June. Make sure you register now to participate in the CX 2020 LIVE sessions.

Nicholas Inston (Birmingham, UK), co-chair of the Vascular […]

CX 2020 LIVE: Vascular Access education and innovation “imperative” during COVID-19 crisis2020-05-22T16:58:23+01:00

CX 2020 LIVE to flag latest guidelines and stent durability in superficial and deep venous programmes

2020-05-20T12:57:01+01:00

Manj Gohel (Cambridge, UK), who is also a member of the CX Venous Executive Board, welcomes you to CX 2020 LIVE, which will include some of the major highlights from the deep and superficial venous programmes.

A number of recently released “important guidelines” in the superficial venous space will be presented […]

CX 2020 LIVE to flag latest guidelines and stent durability in superficial and deep venous programmes2020-05-20T12:57:01+01:00

CX 2020 LIVE: Durability of EVAR, sac diameter and NICE guidelines take the spotlight in first aortic session

2020-05-18T18:09:13+01:00

World-leading vascular surgeon, Stéphan Haulon (Paris, France), who is also a member of the CX Aortic Executive Board, extols the “high-quality” digital educational programme of CX 2020 LIVE and highlights the “very exciting” thoracic aortic and abdominal aortic consensus sessions that will be chaired by a host of other experts […]

CX 2020 LIVE: Durability of EVAR, sac diameter and NICE guidelines take the spotlight in first aortic session2020-05-18T18:09:13+01:00

COVID-19: No evidence of increased aortic emergencies in Lombardy

2020-05-19T10:33:36+01:00

Roberto Chiesa (Milan, Italy), who was at the frontline of the COVID-19 pandemic in the Lombardy region of Italy, shares his team’s experience in tackling vascular and aortic emergencies during this time.

Chiesa outlines the response in the region to the pandemic, including the creation of new intensive care units (ICUs) […]

COVID-19: No evidence of increased aortic emergencies in Lombardy2020-05-19T10:33:36+01:00

Paclitaxel controversy to headline inaugural CX 2020 LIVE session

2020-07-09T23:32:08+01:00


Join a wealth of experts and faculty from around the world for the very first session of CX 2020 LIVE—the inaugural virtual Charing Cross (CX) Symposium—titled ‘Paclitaxel-coated Device Consensus Update’.

Renowned interventional radiologist Andrew Holden (Auckland, New Zealand), who is a member of the CX Peripheral Arterial Executive Board, welcomes the […]

Paclitaxel controversy to headline inaugural CX 2020 LIVE session2020-07-09T23:32:08+01:00
Go to Top